Genetics of cerebral cavernous angioma
1Institut für Humangenetik, Bayerische Julius-Maximilians-Universität Würzburg, Würzburg, Germany. felbor@biozentrum.uni-wuerzburg.de
Zentralblatt Fur Neurochirurgie
|September 8, 2006
Summary
Cerebral cavernous malformations (CCM) are vascular anomalies that can cause headaches, seizures, and stroke. Genetic testing helps identify at-risk individuals for early intervention.
Area of Science:
- Neuroscience
- Genetics
- Vascular Biology
Background:
- Cerebral cavernous malformations (CCM) are vascular anomalies characterized by enlarged, immature capillaries.
- CCM lesions can cause significant neurological symptoms like seizures and stroke.
- Both sporadic and inherited forms of CCM exist, with mutations identified in KRIT1, MGC4607, and PDCD10.
Purpose of the Study:
- To investigate the genetic basis and clinical implications of cerebral cavernous malformations.
- To highlight the role of identified genes in angiogenesis and CCM development.
- To emphasize the importance of genetic counseling and testing for CCM patients and families.
Main Methods:
- Review of existing literature on CCM genetics and clinical presentation.
- Analysis of causal mutations in KRIT1, MGC4607, and PDCD10.
- Discussion of the role of genetic counseling and testing in patient management.
Main Results:
- Mutations in KRIT1, MGC4607, and PDCD10 are implicated in CCM.
- Further genetic factors are likely involved in CCM pathogenesis.
- Genetic testing allows for precise risk assessment and targeted surveillance.
Conclusions:
- Genetic factors play a crucial role in the development of cerebral cavernous malformations.
- Genetic counseling and testing are vital for managing CCM, especially in cases with family history or multiple lesions.
- Early identification of genetic predisposition enables timely medical intervention and reduces patient anxiety.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...


